NCT05709873View on ClinicalTrials.gov

Narcolepsy Nightmare Study

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 22, 2023

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
NarcolepsyNarcolepsy Type 1Narcolepsy With CataplexyNarcolepsy Type 2Narcolepsy Without Cataplexy
Interventions
BEHAVIORAL

Imagery rehearsal therapy

Therapy to reduce nightmares, delivered via videoconference sessions

BEHAVIORAL

Targeted dream control

Therapy to reduce nightmares, delivered in videoconference sessions and lab session. Lab session will involve a sleep study during a daytime nap.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER